Partnership enhances Moffitt Cancer Center’s imaging capabilities for cutting-edge cancer research and treatment Nikon Instruments Inc. today announced the opening of the newest Nikon Center of Excellence at the Moffitt Cancer Center. This prestigious designation underscores Nikon’s commitment to providing cutting-edge imaging technology directly to healthcare facilities such as Moffitt Cancer Center for the purpose of […]
SAN DIEGO — Qureator, a leading AI-powered human disease model company, today announced the appointment of Dr. Branka Mitrovic as its new Chief Scientific Officer (CSO). Dr. Mitrovic brings extensive experience in biomedical research and drug development, with a proven track record in advancing therapeutics for genetic, neurodegenerative, and autoimmune diseases. Dr. Mitrovic’s expertise spans […]
SEATTLE – Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin products. This comes on the heels of Parse invalidating the patents that 10x Genomics had asserted against Parse’s Evercode Whole Transcriptome products and the subsequent cancellation […]
Portfolio includes PAT devices for real-time process monitoring, control and analysis WALTHAM, Mass. and BOSTON — Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices’ desktop portfolio of four […]
Limula LimONE device design render. Bioreactor and centrifuge integrated into one device in a novel way. Proprietary technology demonstrated versatility across CAR T, HSC and other cell therapies. LimONE implements a user-centric design, with flexibility and efficiency at its core. Lausanne, Switzerland, March 4, 2025 – Limula has unveiled LimONE, a disruptive cell therapy manufacturing solution that […]
Comments on Director Nominations Received from Kent Lake BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX) (“Quanterix” or the “Company”), a company fueling scientific discovery through ultra-sensitive biomarker detection, today reiterated the strategic and financial benefits of its proposed acquisition of Akoya Biosciences, which will create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein […]
10x Genomics’ ATAC-Seq patents found valid and infringed PLEASANTON, Calif. — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District of Delaware, Parse agreed – […]
Gelomics is pleased to announce a new strategic partnership with BIOKÉ (a business unit within Cell Signaling Technology Europe B.V. since 2009), a leading provider of innovative life science solutions. Under this agreement, BIOKÉ will serve as Gelomics’ exclusive distributor in the Benelux region (Belgium, the Netherlands, and Luxembourg). This partnership strengthens Gelomics’ commitment to […]
UPPSALA, Sweden and BOSTON — MAGic BioProcessing is thrilled to welcome Ben Krol as the new Director of Sales & Business Development -North America East. Ben joins MAGic BioProcessing from Ecolab and brings extensive expertise in chromatography resins and a deep understanding of the evolving needs of biotech and pharmaceutical industry. His insights into downstream processing and his ability to align technology […]
QT Sense, a deep-tech startup that emerged from the research group of Prof. Dr Schirhagl of the UMCG, has successfully raised €6 million in funding to advance its cutting-edge quantum sensing technology. The funding round was led by QDNL Participations and an angel investor. Additionally, QT Sense, as part of a consortium, secured a grant […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
